Regulations

This document is a practical, in-depth guide detailing how bioreactors meet GMP requirements in regulated industries such as pharmaceuticals. It focuses on the equipment validation lifecycle model, covering user requirements specification (URS), design qualification (DQ), performance qualification (PQ), and ongoing maintenance. It also provides a detailed analysis of sterilization in place (SIP), including validation logic and documentation, offering actionable compliance advice.

This document focuses on the regulatory and standard environment of the bioreactor industry worldwide and domestically. It reviews global standardization led by the ISO, especially the standardization process of ISO/TC 276 WG4 in bioprocessing. It also analyzes mandatory requirements of GMP and other key regulations on bioreactor design, manufacturing and validation, providing a framework for global market access and compliance.

Guangdong’s 2026 biomanufacturing policy highlights bioreactors as key to industry bottlenecks. It backs R&D, ISO-aligned standards, and AI/IoT-driven ecosystems. Biomedicine, cell therapy, and bio-based materials boost demand. Enterprises should prioritize standardization, high-growth sectors, and GMP compliance, accelerating the industry’s tech upgrade and global access.